Clinical Practice Guidelines

Introduction

Clinical practice guidelines (CPGs) are systematically developed statements that link the best available evidence to explicit, actionable recommendations for specific clinical circumstances. They sit at the junction of evidence-based medicine, implementation science and medicolegal practice, and are a recurring theme in basic-science and clinical vivas because they test whether a candidate can appraise evidence, not merely recall it.

The modern exam-relevant understanding rests on three pillars: how a guideline grades its evidence and recommendations (GRADE), how its methodological quality is appraised (AGREE II), and why good guidelines still fail at the bedside (implementation science). A consultant-level answer treats a guideline as a population-level tool that informs but never dictates the care of the individual in front of you.

The Three Pillars

Key Definitions

• Strong recommendation - most informed patients would choose this option; clinicians can apply it to most patients and use it as a quality indicator. Worded "we recommend".
• Weak (conditional) recommendation - choices vary with patient values; requires shared decision-making and should not be used as a rigid quality measure. Worded "we suggest".
• Living guideline - continuously surveilled and updated as new evidence emerges, rather than on a fixed 3-5 year cycle.

Quality of Evidence

Four Levels: High, Moderate, Low, Very Low

Recommendation Strength

Two Levels: Strong or Weak (for or against)

Wording signals strength - surgeons must recognize difference.

AGREE II Tool

Purpose: Assess methodological rigor and transparency of guidelines.

Six Domains (23 items total):

Scoring: Each item rated 1-7. Domain scores calculated as percentage of maximum possible.

Overall Assessment: Would you recommend this guideline for use? Yes / Yes with modifications / No

AGREE II is the gold standard for guideline appraisal.

Why Guidelines Fail

Implementation Strategies

Passive Dissemination: Publication, mailing - LOW effectiveness.

Active Strategies:

• Clinical Decision Support: Electronic alerts, order sets
• Audit and Feedback: Compare performance to guideline, provide feedback
• Academic Detailing: One-on-one education with opinion leaders
• Multifaceted Interventions: Combine strategies - MOST effective

Understanding barriers and targeting interventions improves uptake.

Applying Guidelines in Orthopaedic Practice

Strong Recommendations:

• Apply to most patients unless contraindicated
• Example: "We recommend VTE prophylaxis for major orthopaedic surgery" - give prophylaxis to essentially all patients

Weak Recommendations:

• Shared decision-making required
• Example: "We suggest arthroscopic debridement may be considered for mechanical symptoms in early OA" - discuss alternatives, patient values matter

No Recommendation:

• Evidence insufficient to guide practice
• Use clinical judgment, inform patient of uncertainty

Guideline Limitations

Not Cookbook Medicine:

• Guidelines inform, not dictate decisions
• Individual patient factors may override recommendations
• Rare complications or comorbidities may not be addressed

When Guidelines Don't Apply:

• Atypical patient characteristics (age, comorbidities)
• Patient preferences differ from guideline assumptions
• Local resources unavailable
• New evidence published since guideline development

Wise clinicians use guidelines as a starting point, then individualize based on patient-specific factors.

Major Guideline Developers Worldwide

Side-by-Side: Where Guidelines Genuinely Differ

Registry Evidence Feeding Guidelines

Arthroplasty and fixation guidance increasingly draws on national joint registries rather than RCTs alone:

• NJR (England, Wales, NI, IoM, Guernsey), AJRR (US), AOANJRR (Australia), SHAR (Sweden), Norwegian and NZJR registries supply implant survival and revision-rate data on millions of procedures.
• Registries provide external validity and rare-event detection (e.g. metal-on-metal failure) that trials cannot, but are observational - they inform but cannot prove causation.
• Guideline panels combine registry survival data with RCT functional outcomes and GRADE the resulting body of evidence.

High- vs Limited-Resource Practice Variation

International guidelines require local adaptation; the ADAPTE and GRADE-ADOLOPMENT frameworks formalise this.

Key drivers of variation:

• Resource setting: availability of DOACs, intra-operative imaging, implant range, and theatre capacity changes what is feasible (a strong recommendation is meaningless if the drug or implant is unavailable).
• Local epidemiology: injury patterns, comorbidity burden, and antimicrobial resistance differ by region and alter the benefit-harm balance.
• Local registry data: revision rates for a given implant in the local population may justify departing from an international default.

Example: an international guideline may default to a DOAC for thromboprophylaxis, but a limited-resource setting may justifiably adopt aspirin plus mechanical prophylaxis based on cost, monitoring capacity, and acceptable local outcome data - a defensible local adaptation, not a deviation in error.

Differential: Guideline vs Related Evidence Documents

A frequent viva trap is conflating a clinical practice guideline with other documents that look similar but carry different authority. Know the distinctions.

Controversies and Areas of Uncertainty